News | Cardiac Rehabilitation | March 18, 2026

Empassion Health, Karoo Health Team Up to Support Patients with Advanced Heart Disease and Other Serious Illness

The partnership brings together two organizations with deep expertise in different stages of complex illness to better support patients living with advanced cardiovascular and other serious illness conditions. 

Karoom Empassion, cardiac treatment

March 17, 2026 — Empassion Health, Inc. has announced a strategic partnership with Karoo Health Inc, America’s Cardiac Solution.

The partnership brings together two organizations with deep expertise in different stages of complex illness to better support patients living with advanced cardiovascular and other serious illness conditions. 

Karoo currently enables cardiology networks, health systems and health plans to deliver value-based cardiovascular care through a combination of proprietary technology, dedicated on-site and virtual care teams and contracting capabilities. In partnership with its growing network of approximately 600 cardiac providers in 11 states, Karoo improves outcomes and lowers cost of care for patients across the full spectrum of cardiovascular disease.

As patients progress to later stages of illness — often experiencing worsening symptoms, multiple chronic conditions, declining daily function, and growing caregiver burden — Empassion provides specialized serious illness care. Through advanced patient identification and a curated network of in-home providers, Empassion delivers high-quality palliative and hospice services that reduce avoidable hospitalizations and improve quality of life for patients and caregivers.

Together, the organizations create a clear and seamless transition for patients as their needs evolve from cardiac management to specialized serious illness care. 

Karoo will lead care for patients with cardiovascular disease. When a patient’s heart disease progresses to an advanced stage, Empassion will assume responsibility for the patient’s serious illness care.

“Empassion is world-class at caring for patients with serious illness, and Karoo is world-class at managing cardiovascular disease,” said Chase Knight, Chief Growth Officer at Empassion Health. “Patients benefit when each organization focuses on what it does best, with a clear transition point when the patient’s illness advances.”

Patients with advanced heart disease frequently experience worsening symptoms, complex medical needs, and growing caregiver strain. When these patients reach a stage where quality of life and daily function are significantly impacted, specialized serious illness care becomes essential.

"Patients with heart disease typically live with their condition for years, their needs change, and escalations occur along the way," said Ian Koons, CEO of Karoo Health. "Karoo intervenes in these moments to improve outcomes while still managing cost. When their illness progresses to an advanced stage, Empassion ensures those patients receive the specialized support they deserve."

As value-based care continues expanding, health plans are increasingly seeking partners that can coordinate effectively across specialty programs while maintaining clear accountability for patient care. The Karoo and Empassion partnership provides a structured model that allows care ownership to transition smoothly as patient needs evolve. 

For more information, visit www.karoohealth.com and empassion.com


Related Content

News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
News | Heart Failure

Jan. 6, 2026 — Millions of Americans living with heart failure are not receiving medications that have been proven for ...

Home January 10, 2026
Home
News | Heart Failure

Dec. 16,2025 — The European Society of Cardiology (ESC) has welcomed the adoption of the Safe Hearts Plan, a landmark ...

Home December 23, 2025
Home
News | Heart Failure

Dec. 18, 2025 — Heartflow, Inc., a provider of AI technology for coronary artery disease (CAD), has announced the ...

Home December 22, 2025
Home
News | Heart Failure

Dec. 18, 2025 – Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home December 18, 2025
Home
News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
News | Heart Failure

Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...

Home October 16, 2025
Home
Subscribe Now